← FDA DRUG APPROVALS
FDA ANDA · ANDA040418
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
Sponsor: MALLINCKRODT
APPLICATION
ANDA040418
TYPE
ANDA
ORIGINAL APPROVAL
2001-06-27
LATEST ACTION
2008-03-20
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued
Products
HYDROCODONE BITARTRATE AND ACETAMINOPHENDiscontinued
ACETAMINOPHEN 500MG/15ML, HYDROCODONE BITARTRATE 7.5MG/15ML · SOLUTION · ORAL
Approval history
2008-03-20Manufacturing (CMC) · Supplement 3AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.